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Abstract
This paper considers hypotheses tests for synergistic relationships in epidemiological
studies. Two hypotheses are considered. First, I develop tests of the additive hypothesis
which states that the combined risk from two sources of exposure is the sum of each risk
taken separately. I then develop tests for the hypothesis that a multiplicative relationship
exists for the risks, i.e., that the combined risk is consistent with the multiplication of
the individual risks. Following standard practice in epidemiological studies I consider
tests for both case-referent and cohort (standardized mortality rate) type studies.
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1 Introduction
In epidemiological studies, where there are multiple causes of a particular disease, the
issue arises as to whether the multiple causes have a synergistic relationship so that their
combined eect is both greater than that of either activity alone, and greater than what
one would expect by the sum of their individual risk contributions. Two hypotheses
are frequently tested. The rst hypothesis states that when the sources of disease act
independently, the relative risk of disease, given exposure, is an additive relationship.
Thus, the relative risk of dying from cause A adds to the relative risk of dying from cause
B to determine the combined relative risk of dying when exposed to both A and B. A
second hypothesis states that the relationship between disease and the two causal factors
is multiplicative. In this case, the combined risk is the product of the individual risks.
Of course synergism is itself a concept that is model dependent. For instance, a lack of
synergism in a logit model of risk, as demonstrated by the statistical insignicance of an
interaction term, leads to a multiplicative model of relative risk. Consider the following
example.
Suppose that the probability of dying from a disease depends on two factors, A and
B. Let Æ
A
denote exposure to A, and Æ
B
denote exposure to B. Suppose further that the
probability of dying is logistic and given by:
P [DjÆ
A
; Æ
B
] = 1=

1 + e
 (X
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
where X
A
, X
B
, X
C
, and X
0
are vectors of explanatory factors, and 
j
are true but
unknown coeÆcient vectors. The presence of the term Æ
A
Æ
B
allows for synergism in this
model, and species that the probability of disease may be dierent when causal factors
A and B are both present.
Now, assume that 
C
is zero so that there is no synergistic relationship in the model.
The relative odds of dying when exposed to both agents are:
RO
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A
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= 1]=P [
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Similarly, the relative odds of dying when exposed to A alone are:
RO
A
= P [DjÆ
A
= 1; Æ
B
= 0]=P [

DjÆ
A
= 1Æ
B
= 0]
= exp(X
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0
+X
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A
)
and
RO
B
= P [DjÆ
A
= 0; Æ
B
= 1]=P [

DjÆ
A
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= exp(X
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0
+X
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B
)
and the relative odds of dying from background exposure is
RO
0
= P [DjÆ
A
= 0; Æ
B
= 0]=P [

DjÆ
A
= 0; Æ
B
= 0]
= exp(X
0

0
)
The relative risk is dened as the ratio of the relative odds between the exposure group
and the baseline:
RR
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which says that the relative risk from combined exposure is equal to the ratio of the
relative odds of dying in the exposed population to the relative odds of dying in the
un-exposed population.
Then RR
AB
= (RO
AB
=RO
0
)
= exp(X
A

A
+X
B

B
) and
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= (RO
A
=RO
0
) = exp(X
A

A
); RR
B
= (RO
B
=RO
0
) = exp(X
B

B
)
We see that RR
AB
= RR
A
RR
B
even though the model exhibits synergism.
This paper considers several methods for determining the relative odds ratio, including
the case-control method and the cohort method. The case-control method begins with a
group of individuals who have an observed attribute (such as a given disease or death).
To the cases are matched a set of control individuals. The matching typically is done
at the individual level. For cases and controls, a retrospective determination is made
of exposure to one or more contaminants. From the retrospective exposure, prospective
odds of becoming a case given exposure are determined.
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Cohort studies, by contrast, derive mortality and morbidity rates with reference to
an external reference group. The method is based on the idea of comparing the incidence
of disease in an exposed cohort to the number expected in a \normal" reference group.
Finally, relative risks are sometimes determined using the prevalence method. In
prevalence studies it is common to analyze populations that all have a common exposure
level to some contaminant. In asbestosis studies, it is necessary that all subjects, by
denition, have the same exposure to asbestos. In such cases, the issues of additivity
and multiplicativity are not germane because one can consider the separate eect of
each causal agent. A similar situation occurs in a cohort setting where a companion
population is not used as a reference group. These situations are nevertheless illuminating
in discerning the relative contribution of a second contaminant as it aects the probability
of contracting or dying from a disease. Another example is the analysis of the prevalence
of a disease attribute (such as pleural plaques) in an exposed population.
A prevalence model may be tted with a logistic functional form. The outcome vari-
able is usually the presence or absence of a disease characteristic where the explanatory
factors will include control variables and an indicator for the level of contaminant. If the
cohort provides some level of variance in the level of exposure of both contaminants, an
interactive term can be used to test for synergy, even if this does not provide a test of
additivity or multiplicativity.
This paper focuses on testing the statistical hypotheses of additivity and multiplica-
tivity for the relative risk measures. While other papers have considered the condence
intervals for relative risk measures, no systematic study has been made of the additivity
and multiplicativity hypotheses as a matter of statistics. Therefore, while practice in epi-
demiology has been to say that one or more studies appear to support the multiplicative
model, these studies have not, in general, been statistical statements; i.e., statements
made with attendant levels of condence.
This paper is divided into six sections. In Section 2, we discuss the case-control
method and Wald type tests for the multiplicative and additive hypotheses, derive and
discuss Woolf's method for determining the variance of log-odds ratios (Woolf (1955)),
and discuss maximum likelihood methods for optimization subject to constraints follow-
ing the methods of Gardner and Munford (1980). In Section 3, we discuss other ap-
proaches for determining condence intervals, including Bonferroni Intervals and Monte
Carlo simulation. In Section 4, we describe various synergy indices and how they relate
to tests of hypotheses for additive and multiplicative statistics. In Section 5, we discuss
cohort studies and derive hypothesis tests for the additive and multiplicative statistics.
In Section 6, we discuss prevalence studies and their relationship to cohort studies. In
Section 7, we present our conclusions.
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2 Case-Control Studies
We begin with a table of case-control outcomes at diering exposure levels:
Exposure
None A B A&B TOTAL
cases h
1
h
2
h
3
h
4
h
controls k
1
k
2
k
3
k
4
k
We next express the row counts as fractions:
Exposure
None A B A&B TOTAL
cases 
1

2

3

4
1
controls 
1

2

3

4
1
where ^
j
= h
j
=h and
^

j
= k
j
=k are consistent estimates of the true cell probabilities.
First, we demonstrate that the retrospective odds-ratio from a case control method
provides an approximate estimate of the relative risk of being a \case," given exposure. To
prove this, we examine the odds ratio 
4

1
=
1

4
, although the result clearly generalizes
to other cases. We show that, given exposure level A&B, the odds-ratio approximates
the relative risk of being a case.
We denote cases as D (death from lung cancer for instance) and

D a control (death
from other causes for instance). The combined exposure A&B is referred to as E (expo-
sure). A case with no exposure is denoted

E (no exposure).
The odds-ratio 
4
 
1
=
1
 
4
is equal to
P [EjD]  P [

Ej

D]
P [

EjD]  P [Ej

D]
(1)
since 
4
= P [EjD], 
1
= P [

EjD], 
4
= P [Ej

D], and 
1
= P [

Ej

D]
As the notation implies, the probabilities  and  are conditional probabilities indi-
cating the respective likelihood of having been exposed, given an individual's case-control
status. Of interest is the prospective probability of being a case (i.e., dying) given expo-
sure status.
1
1
Some research studies have used logit analysis to model the conditional probabilities shown above.
This allows the introduction of covariates to provide additional controls in the analysis. For example a
logit model may be used to specify the conditional probabilities: P [AjD], P [

AjD], P [Aj

D], and P [

Aj

D.
A specication of such a model was illustrated in the introduction. The presence of additional covariates
complicates the analysis presented below as the variances and covariances become dependent on the
assumed probability model and on the precision of the parameter estimation.
4
Under a simplifying assumption, the odds-ratio approximates the prospective odds:
P [EjD]  P [

Ej

D]
P [

EjD]  P [Ej

D]
=
P [E;D]=P [D]
P [E;

D]=P [

D]

P [

E;

D]=P [

D]
P [

E;D]=P [D]
=
P [DjE]  P [E]
P [Dj

E]  P [

E]

P [

Dj

E]  P [

E]
P [

DjE]  P [E]
=
P [DjE]
P [Dj

E]

P [

Dj

E]
P [

DjE]
:
=
P [DjE]
P [Dj

E]
(2)
where the approximation results from the observation that P [

Dj

E]=P [

DjE] is close to
one. Case control studies are useful as they provide estimates of the odds P [E]=P [

E]; i.e.,
the relative odds of exposure. The relative odds of being a case P [D]=P [

D] are irrelevant
as they are set by the researcher in the design. They do, however, have an inuence on
the condence of the results.
2.1 Hypothesis Tests for Case-Control Studies|Multiplicative
Case
The relative risk (prospective) of dying given exposure to contaminant A is 
2

1
=
1

2
.
The relative risk of dying given exposure to contaminant B is 
3

1
=
1

3
. The relative
risk of dying if exposed to both contaminants is 
4

1
=
1

4
. The multiplicative hypothesis
states that RR
A&B
= RR
A
RR
B
so that:

4

1
=
1

4
= (
2

1
=
1

2
)  (
3

1
=
1

3
)
Taking logarithms, this becomes:
log 
4
+log 
1
 log 
1
 log 
4
 log 
2
 log 
1
+log 
1
+log 
2
 log 
3
 log 
1
+log
1
+log 
3
= 0
This may be rewritten as
log (
4

2

3

1
)  log (
4

2

3

1
) = 0
or
M = (log
1
  log
2
  log 
3
+ log
4
)  (log 
1
  log 
2
  log 
3
+ log 
4
) = 0
A consistent estimate of this statistic is obtained by replacing 
j
and 
j
with ^
j
and
^

j
.
Deriving the variance of the resulting statistic is complicated by the fact that h
1
,
h
2
, h
3
, and h
4
form a multinomial probability distribution. Similarly k
1
, k
2
, k
3
, and k
4
form a multinomial probability distribution, but one which is independent of the joint
distribution of the h
j
k
j
assumption.
To derive the joint distribution of the log
j
and log 
j
, we begin with results for the
joint distribution of the h
j
. Similar results hold for the outcome of the k
j
. For notational
simplicity we present the results using a common symbol n
j
where n
1
+n
2
+n
3
+n
4
= n.
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Lemma 1 Let Æ
jt
= 1 if outcome j is realized in observation t. The probability that
Æ
jt
= 1 is denoted 
j
. Let n
j
denote the total number of outcome j's that are observed in
the sample of n independent draws, with

1
+ 
2
+ 
3
+ 
4
= 1, n
1
+ n
2
+ n
3
+ n
4
= n,
n
j
=
n
X
t=1
Æ
jt
, n =
n
X
t=1
(Æ
1t
+ Æ
2t
+ Æ
3t
+ Æ
4t
) =
n
X
t=1
1:
Then E(n
j
) = n
j
; V (n
j
) = n
j
(1  
j
), and cov(n
j
; n
k
) =  n
j

k
for j 6= k.
Proof : n
j
=
P
n
t=1
Æ
jt
implies E(n
j
) =
P
n
t=1
E(Æ
jt
) = n
j
since E(Æ
j
) = 1 
j
+0  (1 
j
).
Next V (n
j
) =
P
n
t=1
V (Æ
jt
). But V (Æ
jt
) = E(Æ
jt
) E(Æ
jt
)
2
= 
j
  
2
j
= 
j
(1  
j
). Hence
V (n
j
) = n
j
(1 
j
). Finally cov(n
j
; n
k
) = E[(n
j
 n
j
)(n
k
 n
k
)] = E(n
j
n
k
) n
j
n
k
 
n
k
n
j
+ n
2

j

k
= E(n
j
n
k
)  n
2

j

k
. Now
E(n
j
n
k
) = E
h
(
X
t
Æ
jt
)(
X
t
Æ
kt
)
i
= E
h
X
t
Æ
jt
Æ
kt
+
X
t6=s
Æ
jt
Æ
ks
i
.
But Æ
jt
Æ
kt
= 0 if j 6= k in observation t (only one unique outcome is realized in each trial)
so that the rst sum is exactly zero. The second sum consists of (n
2
 n) terms, which are
the products of independent random variables (since Æ
jt
and Æ
ks
are independent when
t 6= s). The expectation of each term in the second sum is E(Æ
jt
Æ
ks
) = 
j

k
.
Hence E(n
j
n
k
) = (n
2
  n)
j

k
. Combining these results we obtain
cov(n
j
; n
k
) = (n
2
  n)
j

k
  n
2

j

k
=  n
j

k
(3)
Combining these results into the variance covariance matrix for n
j
we obtain:
E
0
B
B
B
@
n
1
n
2
n
3
n
4
1
C
C
C
A
= n
0
B
B
B
@

1

2

3

4
1
C
C
C
A
and
V
0
B
B
B
@
n
1
n
2
n
3
n
4
1
C
C
C
A
= n
0
B
B
B
@

1
(1  
1
)  
1
2  
1

3
 
1

4
 
2

1

2
(1  
2
)  
2

3
 
2

4
 
3

1
 
3

2

3
(1  
3
)  
3

4
 
4

1
 
4

2
 
4

3

4
(1  
4
)
1
C
C
C
A
= n(I   
0
)
where  =

p

1
p

2
p

3
p

4

0
.
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To derive the variance-covariance matrix for log ^
j
= log (n
j
=n), we use a Taylor's series
expansion to rst-order for the logarithm. Then
log ^
j
:
= log 
j
+
1

j
(^
j
  
j
)
where we have evaluated the Taylor's expansion around the true but unknown 
j
. Then
log
0
B
B
B
@
^
1
^
2
^
3
^
4
1
C
C
C
A
=
0
B
B
B
@
log 
1
log 
2
log 
3
log 
4
1
C
C
C
A
+
0
B
B
B
@
1=
1
0
1=
2
0 1=
3
1=
4
1
C
C
C
A
0
B
B
B
@
(^
1
  
1
)
(^
2
  
2
)
(^
3
  
3
)
(^
4
  
4
)
1
C
C
C
A
Hence
V (log ^
j
) =
0
B
B
B
@
1=
1
0
1=
2
0 1=
3
1=
4
1
C
C
C
A
V ar(^
j
  
j
)
0
B
B
B
@
1=
1
1=
2
1=
3
1=
4
1
C
C
C
A
0
=
1
n
0
B
B
B
@
1=
1
0
1=
2
0 1=
3
1=
4
1
C
C
C
A
0
B
B
B
@

1
(1  
1
)  
1
2  
1

3
 
1

4
 
2

1

2
(1  
2
)  
2

3
 
2

4
 
3

1
 
3

2

3
(1  
3
)  
3

4
 
4

1
 
4

2
 
4

3

4
(1  
4
)
1
C
C
C
A

0
B
B
B
@
1=
1
0
1=
2
0 1=
3
1=
4
1
C
C
C
A
0
since V ar(^
j
) =
1
n
2
V ar(n
j
) =
1
n
0
B
B
B
@

1
(1  
1
)  
1
2  
1

3
 
1

4
 
2

1

2
(1  
2
)  
2

3
 
2

4
 
3

1
 
3

2

3
(1  
3
)  
3

4
 
4

1
 
4

2
 
4

3

4
(1  
4
)
1
C
C
C
A
.
Next nV (log ^
j
)
=
0
B
B
B
@
1=
1
0
1=
2
0 1=
3
1=
4
1
C
C
C
A
0
B
B
B
@
(1  
1
)  
1
 
1
 
1
 
2
(1  
2
)  
2
 
2
 
3
 
3
(1  
3
)  
3
 
4
 
4
 
4
(1  
4
)
1
C
C
C
A
=
0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
(4)
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Theorem 2 For the multiplicative hypothesis,
V ar(M) =

1
h
1
+
1
h
2
+
1
h
3
+
1
h
4

+

1
k
1
+
1
k
2
+
1
k
3
+
1
k
4

Proof : The multiplicative hypothesis may be written as
M =

1  1  1 1

0
B
B
B
@
log ^
1
log ^
2
log ^
3
log ^
4
1
C
C
C
A
 

1  1  1 1

0
B
B
B
B
@
log
^

1
log
^

2
log
^

3
log
^

4
1
C
C
C
C
A
Hence
V ar(M) =
1
h

1  1  1 1

0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
0
B
B
B
@
1
 1
 1
1
1
C
C
C
A
+
1
k

1  1  1 1

0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
0
B
B
B
@
1
 1
 1
1
1
C
C
C
A
=
1
h
"
(1) [(1  
1
)=
1
+ 1 + 1  1] +
( 1) [ 1  (1  
2
)=
2
+ 1  1] +
( 1) [ 1 + 1  (1  
3
)=
3
  1] +
(1) [ 1 + 1 + 1 + (1  
4
)=
4
]
#
+ similar terms in 
=
1
h
"
(1  
1
)

1
+ 1 +
(1  
2
)

2
+ 1 +
(1  
3
)

3
+ 1 +
(1  
4
)

4
+ 1
#
+
similar terms in 
=
1
h

1

1
+
1

2
+
1

3
+
1

4

+ similar terms in  (5)
Hence
V ar(M) =

(
1
h
1
+
1
h
2
+
1
h
3
+
1
h
4
) + (
1
k
1
+
1
k
2
+
1
k
3
+
1
k
4
)

=

1
h
1
+
1
h
2
+
1
h
3
+
1
h
4

+

1
k
1
+
1
k
2
+
1
k
3
+
1
k
4

. (6)
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2.2 Woolf's Method
A similar result for the variance of a log odds-ratio itself is derived as follows. Consider
log (
4

1
=
1

4
), the log-odds ratio for the relative risk at the combined exposure level in
a case control study. We have
logRR
A&B
= log (
4

1
=
1

4
) = log (
4
=
1
)  log (
4
=
1
)
Next, without loss of generality, assume that 
1
and 
4
have been normalized so that

1
+
4
= 1 (This may be accomplished by setting 
0
1
= 
1
=(
1
+
4
) and 
0
4
= 
4
=(
1
+
4
).
Now 
0
1
+ 
0
4
= 1 and the log odds-ratio remains unchanged since
logRR
A&B
= log (
0
4

0
1
=
0
1

0
4
) = log (
4

1
=
1

4
).
The expression for log (
4
=
1
) is in the form log


1 

where  = 
4
and (1  ) = 
1
. A
Taylor's series expansion of log


1 

demonstrates that:
log

1  
= log

0
1  
0
+
1  

"
(1  ) + 
(1  )
2
#






0
 (  
0
)
= log

0
1  
0
+
  
0

0
(1  
0
)
. (7)
Next
V ar
 
log
^
(1  ^)
!
=
 
1
^(1  ^)
!
2
^(1  ^)
N
=
1
N^(1  ^)
(8)
where ^ =
1
N
P
N
t=1
Æ
t
is the unbiased estimator of , E(^) =  and V ar(^) = ^(1  
^)=N and N is the number of independent trials resulting in
P
N
t=1
Æ
t
exposure cases (as
compared to non-exposure cases). Similar expressions follow for the theta distribution.
Now
V ar(log (^
4
=^
1
)) =
1
h^
4
^
1
=
h
(h^
4
)(h^
1
)
=
h
1
+ h
4
h
1
h
4
=
1
h
4
+
1
h
1
. (9)
Then
V ar(logRR
A&B
) =
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
9
Note that the repeated application of this result (assuming independence) to the
multiplicative hypothesis would not produce the correct result in a case control setting
because RR
A&B
, RR
A
and RR
B
are mutually correlated.
This result is also known as Woolf's method, and is sometimes written
V ar

log
AD
BC

=
1
A
+
1
B
+
1
C
+
1
D
where RR = AD=BC and A denotes the number of cases with exposure, B denotes cases
without exposure, C denotes controls with exposure, and D denotes controls without
exposure.
It is also possible to derive the covariances of the relative risk measures. Consider
RR
A
= 
2

1
=
1

2
and RR
A&B
= 
4

1
=
1

4
. Then
logRR
A
= (log
2
  log
1
)  (log 
2
  log 
1
)
and
logRR
A&B
= (log
4
  log 
1
)  (log 
4
  log 
1
).
Clearly, these are correlated because of the common components. Consider the  com-
ponents rst (analogous results apply to the  components). Recall that
Var(log ^) =
1
h
0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
But log 
2
  log 
1
=

 1 1 0 0

2
6
6
6
4
log 
1
log 
2
log 
3
log 
4
3
7
7
7
5
so that
Var(log
2
  log
1
) =

1
h


 1 1 0 0

0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
0
B
B
B
@
 1
1
0
0
1
C
C
C
A
=

1
h


 1 1 0 0

2
6
6
6
4
 (1  
1
)=
1
  1
1 + (1  
2
)=
2
0
0
3
7
7
7
5
=
1
h
 
(1  
1
)

1
+ 1 +
(1  
2
)

2
+ 1
!
=

1
h

1

1

+

1
h

1

2

=
1
h
1
+
1
h
2
(10)
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Combining this with the analogous result for log 
2
  log 
1
, we obtain:
Var(logRR
A
) =
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
This is exactly the Woolf result shown above. Similarly:
Var(logRR
A&B
) =
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
and
Var(logRR
B
) =
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
Next consider the covariance between logRR
A
and logRR
A&B
. Again, we consider
the  terms rst. Using the fact that cov(t
0
x; s
0
x) = t
0
Var(x)s for conformable column
vectors, we have, (for the  terms only)
cov[logRR
A
; logRR
B
] =

1
h


 1 1 0 0


0
B
B
B
@
(1  
1
)=
1
 1  1  1
 1 (1  
2
)=
2
 1  1
 1  1 (1  
3
)=
3
 1
 1  1  1 (1  
4
)=
4
1
C
C
C
A
0
B
B
B
@
 1
0
0
1
1
C
C
C
A
=

1
h


 1 1 0 0

2
6
6
6
4
 (1  
1
)=
1
  1
1  1
1  1
1 + (1  
4
)=
4
3
7
7
7
5
=

1
h

1

1

=
1
h
1
(11)
A similar covariance term can be derived for the  terms.
Thus cov[logRR
A
; logRR
A&B
] =
1
h
1
+
1
k
1
.
Combining analogous results for all log-odds ratios we obtain:
Var
2
6
4
logRR
A
logRR
B
logRR
A&B
3
7
5
=
2
6
4
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
3
7
5
We now apply these results to derive the variance of the multiplicative statistic, M . We
have
M = logRR
A&B
  logRR
A
  logRR
B
=

 1  1 1

2
6
4
logRR
A
logRR
B
logRR
A&B
3
7
5
:
11
Hence, V ar(M) =

 1  1 1

2
6
4
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
k
1
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
3
7
5
0
B
@
 1
 1
1
1
C
A
=

 1  1 1

2
6
4
 (
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
)
 (
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
)
(
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
)  (
1
h
1
+
1
k
1
)  (
1
h
1
+
1
k
1
)
3
7
5
=

1
h
1
+
1
h
2
+
1
h
3
+
1
h
4

+

1
k
1
+
1
k
2
+
1
k
3
+
1
k
4

(12)
Hence, this formula for V ar(logM) agrees with our previous derivation.
To test the multiplicative hypothesis, we note that logM should be zero if the mul-
tiplicative hypothesis is true. Therefore we can perform a Wald test using the ratio
of log(M) to its standard error
q
V ar(logM). This will have an asymptotic normal
distribution. (Rao, Linear Statistical Inference and its Applications).
2.3 Hypothesis Tests for Case-Control Studies   Additive Case
We next consider the additive hypothesis, which may be stated:
A = RR
A&B
  (RR
A
+RR
B
  1) = 0
i.e., that the relative risk of dying from contaminants A&B is equal to the sum of the
relative risks from A and B separately less one. To derive a variance for the statistic A,
we note that
V ar(A) = V ar(RR
A&B
) + V ar(RR
A
) + V ar(RR
B
)
 2cov(RR
A&B
; RR
A
+RR
B
)
= V ar(RR
A&B
) + V ar(RR
A
) + V ar(RR
B
)
+2cov(RR
A
; RR
B
)  2cov(RR
A&B
; RR
A
)
 2cov(RR
A&B
; RR
B
) (13)
In the derivations presented thus far, we have found expressions for the variances
and covariances of log relative risks. Clearly, the additive hypothesis requires variances
and covariances of the relative risks themselves. One approach is to develop condence
intervals for the log relative risks, and translate them into condence intervals for the
relative risks by exponentiating the terms in the condence interval inequality. In the
presence of correlation, however, the best one can achieve with this technique are broad
12
intervals based on the Bonferroni inequalities. A second approach uses the fact that if
the log relative risks are approximately normal, then the relative risks are approximately
log normally distributed. Again, the joint distribution of log normal random variables is
not straightforward. Consequently, this approach similarly becomes unworkable.
Instead, we follow Rothman (1976) and rely on a Taylor's series expansion. Speci-
cally, we approximate the logarithm using:
log y
:
= log y
0
+
1
y
0
(y   y
0
) so that V ar(log y)
:
=
1
y
2
0
V ar(y) . Hence:
V ar(y) = y
2
0
V ar(log y)
The accuracy of the approximation improves for y close to y
0
, which we will achieve
by taking y to be a consistent estimate of y
0
.
Collecting the terms required for the variance of the additive statistic, V ar(A), we
have:
V ar(RR
A&B
)
:
= (RR
A&B
)
2

h
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
i
V ar(RR
A
)
:
= (RR
B
)
2

h
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
i
V ar(RR
B
)
:
= (RR
b
)
2

h
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
i
For the covariance terms we employ similar Taylor's expansions. Specically let:
log y
:
= log y
0
+
1
y
0
(y   y
0
) and
log z
:
= log z
0
+
1
z
0
(z   z
0
) . Then
cov(log y; logz)
:
=
1
y
0
z
0
cov(y   y
0
; z   z
0
) so that
cov(y; z)
:
= (y
0
z
0
)  cov(log y; log z). Then:
cov(RR
A
; RR
B
) = (RR
A
RR
B
)  (
1
h
1
+
1
k
1
)
cov(RR
A&B
; RR
A
) = (RR
A&B
RR
A
)  (
1
h
1
+
1
k
1
)
cov(RR
A&B
; RR
B
) = (RR
A&B
RR
B
)  (
1
h
1
+
1
k
1
)
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Then we have:
V ar(A)
:
= (RR
A&B
)
2

h
1
h
1
+
1
h
4
+
1
k
1
+
1
k
4
i
+(RR
A
)
2

h
1
h
1
+
1
h
2
+
1
k
1
+
1
k
2
i
+(RR
B
)
2

h
1
h
1
+
1
h
3
+
1
k
1
+
1
k
3
i
+2(RR
A
RR
b
)  (
1
h
1
+
1
k
1
)
 2(RR
A&B
RR
A
)  (
1
h
1
+
1
k
1
)
 2(RR
A&B
RR
B
)  (
1
h
1
+
1
k
1
) (14)
A Wald test may be conducted using the ratio of A to its standard error
q
V ar(A).
Asymptotically, this will be standard normal, given the limiting distribution of the joint
multinomial probabilities for  and .
Since the Wald tests are valid only asymptotically we also consider a likelihood ratio
approach.
2.4 Maximum Likelihood
The likelihood function for the case control study is
Q
4
i=1

h
i
i

k
i
i
and is maximized subject
to the constraint
P

i
  1 =
P

i
  1 = 0. The log likelihood function is
F =
X
h
i
log 
i
+
X
k
i
log 
i
.
This is maximized subject to the constraints:
F
1
=
X

i
  1 = 0 (15)
F
2
=
X

i
  1 = 0 (16)
and F
3
=

4

1

1

4
 

2

1

1

2
 

3

1

1

3
+ 1 = 0 \additivity" or
F
4
= log (
1

2

3

4
)  log (
1

2

3

4
) = 0 \multiplicativity"
Note that F
3
may be rewritten:
F
3
=

4

4
 

2

2
 

3

3
+

1

1
=

1

1
 

2

2
 

3

3
+

4

4
= 0 (17)
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2.4.1 Additive Constraint
For the additive model, we maximize the Lagrangian
F
A
= F + 
1
F
1
+ 
2
F
2
+ 
3
F
3
where 
1
, 
2
, and 
3
are Lagrange multipliers. The rst order conditions are:
@F
A
@
i
=
h
i

i
+ 
1
+
Æ
i

3

i
= 0 (18)
@F
A
@
i
i
=
k
i

i
+ 
2
 
Æ
i

i

3

2
i
= 0 and (19)
@F
A
@
i
= F
i
= 0 i = 1; 2; 3 (20)
where Æ
1
=  Æ
2
=  Æ
3
= Æ
4
= 1.
It follows that:
X

i
@F
A
@
i
= h+ 
1
= 0 and
X

i
@F
A
@
i
= k + 
2
= 0
Hence, ^
1
=  h and ^
2
=  k and the remaining conditions may be written:
(h
i
  h^
i
)
^

i
+ Æ
i
^
i
^
3
= 0
(k
i
  k
^

i
)
^

i
  Æ
i
^
i
^
3
= 0
and
X
Æ
i
^
i
^

i
= 0
Writing x
i
= ^
i
=
^

i
and solving the rst order conditions implies:
x
i
=
(Æ
i
k
i
h  k^
3
)
q
(Æ
i
k
i
h  k^
3
)
2
  4Æ
i
h
i
hk^
3
2^
3
h
(21)
Since
P
i
Æ
i
x
i
= 0, it follows that:
0 =
X
i

(k
i
h  k^
3
Æ
i
) Æ
i
q
(Æ
i
k
i
h  k^
3
)
2
  4Æ
i
h
i
hk^
3

= kh+
X
i
Æ
i
q
(Æ
i
k
i
h  k^
3
)
2
  4Æ
i
h
i
hk^
3
(22)
This equation in ^
3
may be solved for each of 16 possible sign combinations (+ or - for
each of the four terms in the sum).
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Using x
i
= 
i
=
i
, the rst two rst order conditions may be written
(k
i
  k
i
) = Æ
i
x
i

3
and (h
i
  h
i
) =  Æ
i
x
i

3
Hence, (k
i
  k
i
) =  (h
i
  h
i
), which implies
k
i
+ h
i
= k
i
+ h
i
= 
i
(k + hx
i
) or

i
=
k
i
+ h
i
k + hx
i
. (23)
Now substitute into the rst order condition:
k
i
  k

k
i
+ h
i
k + hx
i

= Æ
i
x
i

3
or
k
i
(k + hx
i
)  k(k
i
+ h
i
) = (k + hx
i
)Æ
i
x
i

3
k
i
k + k
i
x
i
h  k(k
i
+ h
i
) = kÆ
i
x
i

3
+ x
2
i
hÆ
i

3
 kh
i
= x
i
( k
i
h + kÆ
i

3
) + x
2
i
hÆ
i

3
 kh
i
= x
i
(kÆ
i

3
  k
i
h) + x
2
i
hÆ
i

3
 kh
i
Æ
i
= x
i
(kÆ
2
i

3
  k
i
hÆ
i
) + x
2
i
hÆ
2
i

3
Now use Æ
2
= 1 as Æ = 1 or  1. Then:
 kh
i
Æ
i
= x
i
(k
i
  k
i
hÆ
i
) + x
2
i
(h
3
) so that
0 = x
2
i
(h
3
) + x
i
(k
3
  k
i
hÆ
i
) + kh
i
Æ
i
The last equation establishes a bound on x
i
since the discriminant of the quadratic
equation must be positive. The discriminant is:
(k
3
  k
i
hÆ
i
)
2
  4(h
3
)(kh
i
Æ
i
)  0
k
2
i
h
2
  2Æ
i
k
i
hk
3
+ k
2

2
3
  2  2Æ
i
h
i
hk
3
 0
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2
3
  2Æ
i

h
k


3
(k
i
+ 2h
i
) + k
2
i

h
k

2
 0
Next, solving this quadratic at the point of equality to zero for 
3
, we obtain:


3i
=
2Æ
i

h
k

(k
i
+ 2h
i
)
r
4Æ
2
i
h
2
k
2
(k
i
+ 2h
i
)
2
  4k
2
i

h
k

2
2
= Æ
i
 
h
k
!
(k
i
+ 2h
i
)
v
u
u
t
h
2
k
2
(k
i
+ 2h
i
)
2
  k
2
i
 
h
k
!
2
=
 
h
k
!

(k
i
+ 2h
i
)Æ
i

q
k
2
i
+ 4k
i
h
i
+ 4h
2
i
  k
2
i

=

h
k
 
Æ
i
(k
i
+ 2h
i
) 2
q
h
i
(h
i
+ k
i
)

(24)
Since the quadratic has a positive second derivative, the inequalities are 
3
 min

3i
and 
3
 max

3i
.
Setting, a
i
=

h
k

k
i
+ 2h
i
  2
q
h
2
i
+ h
i
k
i

, Gardner and Munford (1980) show that
 min(a
2
; a
3
)  ^
3
 min(a
1
; a
4
).
Unfortunately, while these bounds bracket the true value of ^
3
they are not guaranteed
to produce sign changes in the equation of interest. Therefore, an iterative solution is
required to bracket each of the solutions for ^
3
. We have found that ^
3
= 0 will always
be a trivial solution to the equation above, and should be ignored.
Once ^
3
is found ^
i
and
^

i
are found from the rst order conditions.
2.4.2 Multiplicative Constraint
For the multiplicative model, we maximize the Lagrangian:
F
M
= F + 
1
F
1
+ 
2
F
2
+ 
4
F
4
with F =
X
h
i
log
i
+
X
k
i
log 
i
and
F
1
=
X

i
  1
F
2
=
X

i
  1
F
4
=
X
Æ
i
log 
i
 
X
Æ
i
log 
i
17
we have:
@F
M
@
i
=
h
i

i
+ 
1
+ 
4
Æ
i

i
= 0
@F
M
@
i
=
k
i

i
+ 
2
+ 
4
 (Æ
i
)

i
= 0 . Then:
X

i
@F
M
@
i
=
X
h
i
+ 
1
+ 
4
X
Æ
i
= 0 ) 
1
=  h
X

i
@F
M
@
i
=
X
k
i
+ 
2
+ 
4
X
 (Æ
i
) = 0 ) 
2
=  k
h
i

i
  h+

4
Æ
i

i
= 0 ) h
i
  h
i
+ 
4
Æ
i
= 0
h
i
= h
i
+ 
4
Æ
i

i
=
h
i
+ Æ
i

4
h
k
i

i
+ 
2
+ 
4
 
 Æ
i

i
!
= 0 )
k
i

i
  k + 
4
 
 Æ
i

i
!
= 0 )
k
i
  k
i
+ 
4
( Æ
i
) = 0
 k
i
= 
4
Æ
i
  k
i

i
=

4
Æ
i
  k
i
 k
=
k
i
  
4
Æ
i
h
Finally, substituting into the constraint implies:
"
h
1
+ Æ
1

4
h
# "
k
2
  Æ
2

4
k
# "
k
3
+ Æ
3

4
k
# "
h
4
+ Æ
4

4
h
#
  similar terms = 0
which implies (h
1
+ 
4
)(k
2
+ 
4
)(k
3
+ 
4
)(h
4
+ 
4
)  similar terms = 0.
2.4.3 Unconstrained Maximum Likelihood
The log likelihood under the constraint of additivity or multiplicativity is
P
h
i
log ^
i
+
P
k
i
log
^

i
. For the unconstrained case we maximize the Lagrangian
L =
X
h
i
log
i
+
X
k
i
log
^

i
+  
1
h
X

i
  1
i
+  
2
h
X

i
  1
i
The rst order conditions are
@L
@
i
=
h
i

i
+  
1
= 0 and
@L
@ 
1
=
X

i
  1 = 0
@L
@
i
=
k
i

i
+  
2
= 0 and
@L
@ 
2
=
X

i
  1 = 0
18
These equations imply that ^
i
= h
i
=h and
^

i
= k
i
=k for the unconstrained maximum
likelihood.
Hypothesis tests may be based on  2(log likelihood unconstrained   log likelihood
constrained), which has a 
2
distribution with one degree of freedom.
While the additive and multiplicative models are non-nested, a comparison of the log
likelihood values provides a basis for a non-nested hypothesis test.
3 Bonferroni Intervals and Monte Carlo Simulations
3.1 Bonferroni Interval
The additive statistic A = RR
A&B
 RR
A
 RR
B
  1 is composed of three random vari-
ables. A condence interval for each component may be established using the variance of
the log-odds ratio. Set at appropriate levels, these condence intervals may be combined
using basic results from probability theory. For a 95 percent condence interval, chose a
signicance level such that one third of one half of 5 percent probability is in each tail of
a normal distribution. Then:
prob[ 2:39  N(0; 1)  2:39] = 1 
:05
6
= 0:98334
Since (log
^
RR   logRR)= 
A
N(0; 1) we have
prob[ 2:39  log
^
RR  logRR  2:39] = 0:98334
or
prob[ 2:39 + log
^
RR  logRR  2:39 + log
^
RR] = 0:98334
so that
prob[
^
RRe
 2:39
 RR 
^
RRe
2:39
] = 0:98334
Similarly,
prob[
^
RR
A&B
e
 2:39
RR
A&B
 RR 
^
RR
A&B
e
2:39
RR
A&B
] = 0:98334
and so forth for
^
RR
A
and
^
RR
B
. Similarly:
Prob[C
A&B
low
 RR
A&B
 C
A&B
high
] = :98334
Prob[C
A
low
 RR
A
 C
A
high
] = :98334
Prob[C
B
low
 RR
B
 C
B
high
] = :98334
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Denoting the intervals within square brackets as A,B, and C, we have by the Bonferroni
inequality:
prob[A \ B \ C]  1 

P (A
c
) + P (B
c
) + P (C
c
)

Then
prob[C
A&B
low
 RR
A&B
 C
A&B
high
\
 C
A
high
  RR
A
  C
A
low
\
 C
B
high
  RR
B
  C
B
low
]  1  :05 = :95 (25)
so that
prob[C
A&B
low
  C
A
high
  C
B
high
 RR
A&B
 RR
A
  RR
B
 C
A&B
high
  C
A
low
  C
B
low
]  :95
and
prob[C
A&B
low
  C
A
high
  C
B
high
  1  A  C
A&B
high
  C
A
low
  C
B
low
  1]  :95
As noted before, given the tendency of the intervals to be broad and imprecise, these
intervals should be rejected in favor of Wald or Likelihood Ratio tests.
3.2 Simulation Methods
Consistent estimates of the 
j
and 
j
are formed using h
j
=h and k
j
=k respectively. A
Monte Carlo technique draws a random multinomial deviate with marginal probabilities

j
and 
j
. Then, the empirical distribution of the statistics M and A are formed using
repeated simulations. The empirical distributions establish condence intervals centered
around the realized value of the statistic. If these condence intervals contain zero, then
the hypothesis is not rejected.
4 Synergy Indices
4.1 Rothman's S Index
Rothman (1976) considers the independently-acting agents A and B and a background
eect C. C is assumed to act independently of A and B.
Let P
T
denote the probability that disease develops when both A and B are present
in addition to the background C. P
A
is the probability that disease develops if A were
20
to act in isolation (without background). We dene P
B
similarly. P
C
is the probability
of getting disease from background only. Then
P
T
= P [A [B [ C]
= P [A] + P [B] + P [C]  P [A \ B]  P [A \ C] 
P [B \ C] + P [A \ B \ C] (26)
Now, under independence we have:
P
T
= P [A] + P [B] + P [C]  P [A]P [B]  P [A]P [C]  P [B]P [C] + P [A]P [B]P [C]
Let R
AB
= P
T
denote the combined risk.
Let R
A
= P [A [ C] = P [A] + P [C]  P [A]P [C]
Let R
B
= P [B [ C] = P [B] + P [C]  P [B]P [C]
Let R
0
= P [C]
Then, under independence:
R
AB
 R
0
= (R
A
  R
0
) + (R
B
 R
0
) 
P
A
P
B
(1  P
C
)(1  P
C
)
(1  P
C
)
= (R
A
  R
0
) + (R
B
 R
0
) 
(R
A
  R
0
)(R
B
  R
0
)
(1  R
0
)
(27)
Rothman's synergy index is dened as the ratio of the left-hand side of this equation to
the right-hand side.
S =
(R
AB
 R
0
)
(R
A
  R
0
) + (R
B
 R
0
) +
(R
A
 R
0
)(R
B
 R
0
)
(1 R
0
)
Under independence, the numerator and denominator will be equal and the synergy index
will equal one. Ignoring the product terms in the denominator, which are likely to be
small, Rothman's index becomes:
S =
(R
AB
 R
0
)
(R
A
  R
0
) + (R
B
 R
0
)
=
RR
AB
  1
RR
A
+RR
B
  2
where RR
AB
= RR
AB
=R
0
etc. When S = 1, we obtain:
RR
AB
  1 = RR
A
+RR
B
  2 or
RR
AB
= RR
A
+RR
B
  1 (28)
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which we recognize as the additive hypothesis.
An alternative expression for Rothman's S index is
S =
ERR
AB
ERR
A
+ ERR
B
where ERR
AB
= RR
AB
  1 and ERR
A
= RR
A
  1 etc. Here, ERR denotes excess
relative risk.
4.2 Attributable Proportion
The attributable proportion is dened as the excess relative risk compared to the additive
model divided by the combined relative risk. Formally,
AP =
ERR
AB
  (ERR
A
+ ERR
B
)
(ERR
AB
+ 1)
=
(R
AB
=R
0
  1) 
h
(R
A
=R
0
) + (R
B
=R
0
  1)
i
[R
AB
=R
0
  1 + 1]
=
R
AB
  R
0
  (R
A
+R
B
  2R
0
)
R
AB
=
R
AB
  (R
A
+R
B
  R
0
)
R
AB
=
RR
AB
  (RR
A
+RR
B
  1)
RR
AB
(29)
When the additive model is correct, AP = 0.
Rothman's index S and the attributable proportion AP measure departure from
additivity. They do not include the multiplicative hypothesis as a natural alternative.
Therefore we consider an alternative which nests both hypotheses.
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4.3 Additive-Multiplicative Measure
Dene
 =
(RR
A&B
  1)  (RR
A
  1)  (RR
B
  1)
(RR
A
  1)(RR
B
  1)
=
RR
A&B
  RR
A
 RR
B
+ 1
(RR
A
  1)(RR
B
  1)
(30)
Note that when  = 0 the additive hypothesis is true. When  = 1 we have:
RR
A&B
= RR
A
  RR
B
+ 1 = RR
A
RR
B
  RR
A
 RR
B
+ 1
which implies: RR
A&B
= RR
A
RR
B
, i.e. the multiplicative hypothesis.
While diÆcult, a condence interval may be derived by examining the distribution of
log . Note that
log  = logA 

log (RR
A
  1) + log (RR
B
  1)

where A is the additive statistic. Then
V ar(log ) = V ar(logA)  V ar

log (RR
A
  1)

+ V ar

log (RR
B
  1)

+2cov
h
log (RR
A
  1); log (RR
B
  1)
i
 2cov
h
logA; log (RR
A
  1)
i
 2cov
h
logA; log (RR
B
  1)
i
: (31)
For case-control studies, we have previously derived these components. However, the
utility of the expansion is questionable given that when the additive hypothesis is true,
the log transformation is not dened.
5 Cohort Studies
Cohort studies derive standardized morbidity or mortality rates with reference to an
external reference group. The standardized mortality rate (SMR) is also known as an
observed to expected ratio because it is constructed by computing the expected number
of outcomes (deaths) based on the external reference group's rates. Given the large
samples from which they are typically based, the latter rates are assumed to be known
without error.
The cohort method compares the death rates between groups for those exposed to
contaminant A (with or without exposure to B) and for those not exposed to contaminant
A (with or without exposure to B). For present purposes, contaminant A will be smoking,
while contaminant B will be asbestos. Death rates are calculated and given in the
following 2 2 table:
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non-smoking smoking
asbestos d
NS
A
d
S
A
non-asbestos d
NS
NA
d
S
NA
The cohort method follows a group of individuals with some exposure to asbestos.
Death rates are determined over time for this cohort. A sample of individuals from a
non-asbestos exposed population is matched to the exposed population at the aggregate
level (i.e., there is a similar number of individuals of each age group).
Before discussing the derivation of the death rates d
i
j
, we note that cohort studies
make each cell of the 2 2 table independent by design. This greatly simplies the hy-
pothesis testing and determination of condence intervals. Relative risks are determined
as follows:
RR
A
= relative risk of asbestos exposure = d
NS
A
=d
NS
NA
RR
S
= relative risk of smoking exposure = d
S
NA
=d
NS
NA
RR
AS
= the relative risk of combined exposure = d
S
A
=d
NS
NA
The additive hypothesis is stated as:
RR
AS
  RR
A
  RR
S
+ 1 = 0
or
d
S
A
d
NS
NA
=
d
NS
A
d
NS
NA
+
d
S
NA
d
NS
NA
  1
or
d
S
A
= d
NS
A
+ d
S
NA
  d
NS
NA
or
A

= d
NS
A
+ d
S
NA
  d
S
A
  d
NS
NA
Under additivity A

= 0.
The multiplicative hypothesis is stated as:
RR
AS
= RR
A
RR
S
= 0
or
d
S
A
d
NS
NA
 
d
NS
A
d
NS
NA

d
S
NA
d
NS
NA
= 0
or
d
S
A
 d
NS
NA
  d
NS
A
 d
S
NA
= 0 (32)
or
log d
S
A
+ log d
NS
NA
  log d
NS
A
  log d
S
NA
= 0
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or
M

= log d
NS
A
+ log d
S
NA
  log d
S
A
  log d
NS
NA
= 0
We note that the multiplicative statistic is similar to the additive statistic with the
exception that it is stated as a sum of logarithms. This suggests that the two hypotheses
may be nested using a Box-Cox transformation.
It is worth noting that (32) implies
d
NS
A
d
S
A
=
d
NS
NA
d
S
NA
which states that the columns in the table are proportional to one another. Similarly,
the rows are in proportion if the multiplicative hypothesis is correct. These are common
statements of independence and can be tested via Pearson Chi-squared statistics for
such tables. Finally, given the relationship between contingency tables and the log-linear
model, we should expect a direct test of the multiplicative hypothesis from the log-linear
model.
Suppose log (P [Y
1
; Y
2
]) = 
0
+ 
1
Y
1
+ 
2
Y
2
+ 
12
Y
1
 Y
2
Then
log (P (0; 0)) = 
0
log (P (0; 1)) = 
0
+ 
2
log (P (1; 0)) = 
0
+ 
1
log (P (1; 1)) = 
0
+ 
1
+ 
2
+ 
12
If P (0; 0) is estimated by d
NS
NA
, P (1; 0) by d
NS
A
, P (0; 1) by d
S
NA
, and P (1; 1) by d
S
A
(after
suitable normalization), then the multiplicative hypothesis may be stated as:
M

= (
0
+ u
1
) + (
0
+ 
2
)  (
0
+ 
1
+ 
2
+ 
12
)  (
o
) =  
12
Then, M

= 0 (the multiplicative hypothesis) if and only if the interaction parameter

2
= 0 in the log-linear model.
5.1 Determination of Death Rates
The death rate is dened as the number of deaths per 100,000 person years. This is
typically measured by the number of deaths observed in the cohort divided by the number
of person years multiplied by 100,000.
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For example, suppose that a particular cohort has N
NS
A
individuals who are non-
smokers but who are exposed to asbestos. Suppose that these N
NS
A
individuals are
followed for Y
NS
A
person years (on average Y
NS
A
=N
NS
A
years per person). Suppose that
h
NS
A
of these individuals die during the period of observation. Then
d
NS
A
=
 
h
NS
A
N
NS
A
! 
N
NS
A
Y
NS
A
!
 100; 000:
The stochastic component in the expression is the binomially distributed random
variable h
NS
A
that denotes the number of observed deaths in N
NS
A
trials. Let P
NS
A
denote
the true but unobserved probability of dying. Then
^
P
NS
A
= h
NS
A
=N
NS
A
is a consistent
estimate of P
NS
A
.
Now E(
^
P
NS
A
) = P
NS
A
and V ar(
^
P
NS
A
) =
P
NS
A
(1  P
NS
A
)
N
NS
A
:
Then
V ar(d
NS
A
) = V ar(
^
P
NS
A
) 
"
N
NS
A
Y
NS
A
#
2
 100; 000
2
When logarithmic transformations are employed we have
log d
NS
A
= log
^
P
NS
A
+ log
"
N
NS
A
Y
NS
A
#
+ log (100; 000) :
Recall that a Taylor's series expansion shows that log
^
P
:
= logP
0
+
1
P
0
(
^
P   P
0
) so that
V ar(log
^
P ) =
1
P
2
0
P
0
(1  P
0
)
N
=
(1  P
0
)
P
0
N
Then
V ar(log (d
NS
A
))
:
=
(1 
^
P
NS
A
)
^
P
NS
A
N
NS
A
Before proceeding with the formula for the variance of the A

and M

statistics, we
note that replacing P
NS
A
by
^
P
NS
A
in the variance formula is valid asymptotically. Some
researchers have noted that it may be more accurate in small samples to use a chi-square
approximation.
To do this, we set 
2
=
(
^
P P )
P (1 P )=N
. Then we set the 
2
value to a critical level for the
appropriate size test. Let 
2
r
be the critical value. Then

2
r
=
(
^
P   P )
2
P (1  P )=N
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so that
^
P   2
^
PP + P
2
= 
2
r
P (1  P )=N
=
P
N

2
r
 
P
2
N

2
r
(33)
Then
P
2
 

2
r
N
+ 1
!
+ P
 
 
2
r
N
  2
^
P
!
+
^
P
2
= 0
is a quadratic equation that may be solved for P . A condence bound is derived us-
ing the two solutions of the quadratic equation.
5.2 Variance of the Additive and Multiplicative Statistics
Next, we derive the variance of the additive and multiplicative statistics for cohort studies.
Recall that
A

= (d
NS
A
  d
S
A
)  (d
NS
NA
  d
S
NA
)
For the non-asbestos exposed cohort, the rates d
NS
NA
and d
S
NA
are determined from
large samples and are considered non-stochastic. Therefore the variance is determined
from the components d
NS
A
and d
S
A
, which are stochastic but independent. In this case,
V ar(A

) = V ar(d
NS
A
) + V ar(d
S
A
)
=
"
^
P
NS
A
(1 
^
P
NS
A
)
N
NS
A
# 
N
NS
A
Y
NS
A
!
2
 (100; 000)
2
+
"
^
P
S
A
(1 
^
P
S
A
)
N
S
A
# 
N
S
A
Y
S
A
!
2
 (100; 000)
2
(34)
For the multiplicative statistic,
M

= [(log d
NS
A
)  (log d
S
A
)]  [(log d
NS
NA
)  (log d
S
NA
)]
so that
V ar(M

) =
(1 
^
P
NS
A
)
^
P
NS
A
N
NS
A
+
(1 
^
P
S
A
)
^
P
S
A
N
S
A
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These variances are used to calculate standard errors, condence intervals, and Wald
tests for the additive and multiplicative hypotheses.
For instance, M

=
q
V ar(M

) is asymptotically standard normally distributed under
the null hypothesis that M

= 0.
5.3 Variance of the Synergy Index
To derive the variance of S, V ar(S) we rst nd logS.
logS = log (R
AB
 R
0
)  log
h
(R
A
 R
0
) + (R
B
  R
0
)
i
For cohort studies, we have:
logS = log (RR
AB
  1)  log
h
(RR
A
  1) + (RR
B
  1)
i
= log
 
d
A
S
d
NS
NA
  1
!
  log
" 
d
NS
A
d
NS
NA
  1
!
+
 
d
S
NA
d
NS
NA
  1
!#
= log(d
S
A
  d
NS
NA
)  log(d
NS
A
+ d
S
NA
  2d
NS
NA
)
V ar(logS) =
V ar(d
S
A
)
(d
S
A
  d
NS
NA
)
2
+
V ar(d
NS
A
)
(d
NS
A
+ d
S
NA
  2d
NS
NA
)
2
(35)
where we have used the fact that V ar(d
S
NA
) = V ar(d
NS
NA
) = 0 in cohort studies since
these variables are assumed to be non-stochastic.
For case-control studies, we have:
V ar(logS) =
V ar(RR
AB
)
(RR
AB
  1)
2
+
V ar(RR
A
) + V ar(RR
B
) + 2cov(RR
A
; RR
B
)
(RR
A
+RR
B
  2)
2
(36)
where the relevant components were derived above in the case-control section.
6 Conclusion
Case-control, cohort, and prevalence studies provide varying types of information to
determine relative risks and attendant condence levels. We have considered several
methods for testing additivity and multiplicativity hypotheses using Wald and likelihood
ratio techniques. In these cases, we have relied on asymptotic expectation for which the
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small sample populations are unknown. Our empirical results are reported in a companion
paper and, generally, we nd agreement in our conclusions regarding the additivity or
multiplicativity hypothesis whether the analysis is conducted using Wald or likelihood
ratio methods.
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